scispace - formally typeset
Y

Yuqing Wang

Researcher at University of Toronto

Publications -  17
Citations -  6390

Yuqing Wang is an academic researcher from University of Toronto. The author has contributed to research in topics: Autophagy & Mitophagy. The author has an hindex of 8, co-authored 8 publications receiving 5726 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

ROS-induced mitochondrial depolarization initiates PARK2/PARKIN-dependent mitochondrial degradation by autophagy

TL;DR: It is shown that elongated mitochondria are more resistant to ROS-induced damage and mitophagy compared with fragmented mitochondria, suggesting that mitochondrial morphology has an important role in regulating ROS andMitophagy.
Journal ArticleDOI

NBR1 acts as an autophagy receptor for peroxisomes

TL;DR: Results suggest that NBR1 is the specific autophagy receptor for pexophagy, and that substrate selectivity is partly achieved by N BR1 itself by coincident binding of the J and UBA domains to peroxisomes.
Journal ArticleDOI

VAPs and ACBD5 tether peroxisomes to the ER for peroxisome maintenance and lipid homeostasis.

TL;DR: This study reports that the ER-resident VAMP-associated proteins A and B interact with the peroxisomal membrane protein acyl-CoA binding domain containing 5 (ACBD5) and that this interaction is required to tether the two organelles together, thereby facilitating the lipid exchange between them.
Journal ArticleDOI

Deubiquitinating enzymes regulate PARK2-mediated mitophagy

TL;DR: 2 mitochondrial DUBs, USP30 and USP35, regulate PARK2-mediated mitophagy, and this study provides clear rationales for the design and development of drugs for the therapeutic treatment of neurodegenerative diseases such as Parkinson and Alzheimer diseases.